NR1H4 and metabolic dysfunction-associated steatohepatitis: Our current data showed that GC treatment significantly upregulated the expression of FXR protein in the liver tissues of NASH mice, whereas knockout of the FXR gene blocked the effects of GC on NASH mice, further supporting that FXR does play a role in regulating the effects of GC as an anti-NASH agent in vivo.